Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
To evaluate if 0.04% MMC application at the ostium enhances the outcome of non-endoscopic endonasal dacryocystorhinostomy (NEED) in individuals with primary acquired nasolacrimal duct obstruction (PANDO)
Nuclear -catenin upregulates ZEB1, a key EMT transcription factor, which enhances invasiveness and suppresses DNA repair, thereby reducing chemosensitivity to agents such as doxorubicin
J., Kannan, K
It has the molecular formula CHNOS, a molecular weight of 5135.9 g/mol, and CAS number 901758-09-6
Use In Driving And Operating Machinery There is no known interaction between HAVGLO INJECTION 1 and the ability to operate machinery or drive
US$ 24.11
US$ 28.44
US$ 23.67
